Skip to main content

Dyadic International Inc

DYAI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001213809

In the last 90 days, Dyadic International Inc insiders filed 0 open-market purchases and 2 sales; 39 institutions reported holding it in 13F filings for Q2 2026, worth $4.14M in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Dyadic International Inc changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of DYAI: Q1 2024 compared with Q2 2024
MeasureQ1 2024Q2 2024Change
Holders3339+6
Shares4.52M4.68M+167.4K (+3.7%)
Value$7.54M$6.93M−$610.4K (−8.1%)

New holders (8)

Institutions that held Dyadic International Inc at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to DYAI in Q2 2024
InstitutionSharesValue% of portfolio
Robertson Stephens Wealth Management, LLC49,969$74.0K0.00%
Thompson Davis & Co., Inc.34,000$50.3K0.04%
LPL Financial LLC14,849$22.0K0.00%
Wolverine Trading, LLC13,647$20.2K0.00%
UBS Group AG9,764$14.5K0.00%
Citigroup Inc187$2770.00%
Bank of America Corp168$2490.00%
Simplex Trading, LLC37$00.00%

Sold out (2)

Institutions that held Dyadic International Inc at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of DYAI in Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Group One Trading, L.P.206$344
FMR LLC150$251